These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28097530)

  • 41. Prevention of Hepatitis B Virus Infection and Liver Cancer.
    Chang MH
    Recent Results Cancer Res; 2021; 217():71-90. PubMed ID: 33200362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B virus vaccine for patients with hepatitis C virus infection.
    Chlabicz S; Grzeszczuk A
    Infection; 2000; 28(6):341-5. PubMed ID: 11139151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural history of hepatitis-related hepatocellular carcinoma.
    But DY; Lai CL; Yuen MF
    World J Gastroenterol; 2008 Mar; 14(11):1652-6. PubMed ID: 18350595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Towards the elimination of hepatitis B and hepatocellular carcinoma.
    Spearman CW
    S Afr Med J; 2018 Aug; 108(8b):13-16. PubMed ID: 30182907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Current status and therapeutic strategy for hepatocellular carcinoma].
    Unoura M; Adachi K; Kawai H; Inagaki Y; Kaneko S; Kobayashi K
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):608-14. PubMed ID: 2157367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
    Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
    BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pathogenesis of hepatitis B virus-related hepatocellular carcinoma].
    Zhang Y; Guo J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):152-6. PubMed ID: 26983488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Human hepatitis B virus and hepatocellular carcinoma].
    Rivkina MB; Tikhonenko TI
    Mol Gen Mikrobiol Virusol; 1990 Feb; (2):3-9. PubMed ID: 2159110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of HBV therapy on the incidence of hepatocellular carcinoma.
    Triolo M; Della Corte C; Colombo M
    Liver Int; 2014 Feb; 34 Suppl 1():139-45. PubMed ID: 24373091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B virus: from diagnosis to treatment.
    Dény P; Zoulim F
    Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now.
    Bharadwaj M; Roy G; Dutta K; Misbah M; Husain M; Hussain S
    Cancer Metastasis Rev; 2013 Jun; 32(1-2):229-68. PubMed ID: 23114844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
    Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
    Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocellular carcinoma and hepatitis B virus.
    Chan HL; Sung JJ
    Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
    Tharayil VS; Roberts LR
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B vaccines: protective efficacy and therapeutic potential.
    Michel ML; Tiollais P
    Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan.
    Oda T
    Jpn J Cancer Res; 1999 Oct; 90(10):1051-60. PubMed ID: 10595731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
    Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.